Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ProMIS Neurosciences Inc
PMN
Healthcare
Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational...
discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PMN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(198)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Jul 15, 2024 8:28pm
Day late and dollar short
I can only imagine how many times we have heard them talk about increasing shareholder value while repricing their option shares lower. This bunch get paid to think!!!! Oh boy are we in trouble, all
...more
(36)
•••
M101
X
View Profile
View Bullboard History
Post by
M101
on Jul 15, 2024 3:21pm
it's like trying to sell Biden
https://endpts.com/facing-a-tepid-alzheimers-market-lilly-looks-to-build-a-sense-of-urgency-to-jumpstart-sales-of-donanemab/
(36)
•••
M101
X
View Profile
View Bullboard History
Comment by
M101
on Jul 15, 2024 12:34pm
RE:RE:RE:Clinical Study data?
It might have violated the dilution rule, or maybe they got around it with the penny warrants. But why are penny warrants even legal? Why are any warrants legal? These devices are designed exactly for
...more
(198)
•••
goldtech
X
View Profile
View Bullboard History
Comment by
goldtech
on Jul 13, 2024 2:19pm
RE:RE:Clinical Study data?
You are correct jumpingjack, this board approved an illegal funding on the last financing and they never seem to deliver but increase wages for themselves. They may be getting awfully close to a
...more
(2)
•••
Jumpinjackfast
X
View Profile
View Bullboard History
Comment by
Jumpinjackfast
on Jul 12, 2024 2:50pm
RE:Clinical Study data?
If they are it's for a extended paycheck , biotechs are know to be Bold Face Liar's . The new CEO was a board memeber when they again destroyed shareholder value , with a outrageous 1for 60 on
...more
(21)
•••
BottomBroker
X
View Profile
View Bullboard History
Comment by
BottomBroker
on Jul 12, 2024 2:14pm
RE:Clinical Study data?
To be fair, data was expected in "mid" 2024. No guarantee it would be July specifically. Another poster implied that Promis was witholding the data, but when asked for proof, didn'
...more
(12)
•••
Hafness
X
View Profile
View Bullboard History
Post by
Hafness
on Jul 12, 2024 1:07pm
Clinical Study data?
I thought we were supposed to have some data from the clinical study by now? Wonder why they are holding it.
(198)
•••
goldtech
X
View Profile
View Bullboard History
Comment by
goldtech
on Jul 12, 2024 10:38am
RE:RE:Dilution
Only when they dilute maliciously without getting the stock at higher levels and minimise dilution. The last disaster had this crazy lame board drive the stock down from 8.95 to less than 2 dollars
...more
(106)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jul 12, 2024 9:01am
RE:Dilution
Dilution concerns for startups are overrated, especially for Biotechs. It comes with the territory. It's unavoidable. G1945V
(198)
•••
goldtech
X
View Profile
View Bullboard History
Post by
goldtech
on Jul 11, 2024 2:51pm
Dilution
Anti-dilution measures can be implemented to protect existing shareholders from unfair dilution. Investors should carefully evaluate the risks and benefits associated with stock dilution before making
...more
(21)
•••
BottomBroker
X
View Profile
View Bullboard History
Comment by
BottomBroker
on Jul 10, 2024 9:41am
RE:it's okay
Don't get me wrong, I'm happy. I just hope it's going up for the right reason(s).
(93)
•••
Gbathat
X
View Profile
View Bullboard History
Post by
Gbathat
on Jul 09, 2024 10:37pm
$PMN up, $ABOS down
inverse relationship developing? why is $ABOS going down when they have all that cash? I bought some $ABOS just in case it is a dip. $PMN starting to soar!!! Let's go!!!!
...more
(93)
•••
Gbathat
X
View Profile
View Bullboard History
Post by
Gbathat
on Jul 09, 2024 10:33pm
it's okay
it's okay to be happy that the stock is going up could be 'buy the rumor' could be info leakage could be nothing but I'm okay with the trajectory! At a minimum, the
...more
(4)
•••
milafeijo
X
View Profile
View Bullboard History
Comment by
milafeijo
on Jul 09, 2024 2:46pm
RE:Violation of NASDAQ rule
Hi, should we report it to Nasdaq somehow???
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success